EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Ian Marsh, Dhiraj Kumar, Gabriel Ghiaur, Philip Imus, Steven P Rowe, Robert F Hobbs, Christian B Gocke, Sridhar Nimmagadda iD

Advanced Science · 2024

DOI: 10.1002/advs.202308617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Ajay Kumar Sharma und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Multiple Myeloma, ADP-ribosyl Cyclase 1, Positron-Emission Tomography. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited availability of molecularly targeted low‐molecular‐weight imaging agents for monitoring multiple myeloma (MM)‐targeted therapies has been a significant challenge in the field. In response, a first‐in‐class peptide‐based radiotracer, [ 68 Ga]Ga‐AJ206, is developed that can be seamlessly integrated into the standard clinical workflow and is specifically designed to noninvasively quantify CD38 levels and pharmacodynamics by positron emission tomography (PET). A bicyclic peptide, AJ206, is synthesized and exhibits high affinity to CD38 ( K D : 19.1 ± 0.99 × 10 −9 m ) by surface plasmon resonance. Further, [ 68 Ga]Ga‐AJ206‐PET shows high contrast within 60 min and suitable absorbed dose estimates for clinical use. Additionally, [ 68 Ga]Ga‐AJ206 detects CD38 expression in cell line‐derived xenografts, patient‐derived xenografts (PDXs), and disseminated disease models in a manner consistent with flow cytometry and immunohistochemistry findings. Moreover, [ 68 Ga]Ga‐AJ206‐PET successfully quantifies CD38 pharmacodynamics in PDXs, revealing increased CD38 expression in the tumor following all‐trans retinoic acid (ATRA) therapy. In conclusion, [ 68 Ga]Ga‐AJ206 exhibits the salient features required for clinical translation, providing CD38‐specific high‐contrast images in multiple models of MM. [ 68 Ga]Ga‐AJ206‐PET could be useful for quantifying total CD38 levels and pharmacodynamics during therapy to evaluate approved and new therapies in MM and other diseases with CD38 involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesMultiple MyelomaADP-ribosyl Cyclase 1Positron-Emission TomographyAnimalsMiceHumansRadiopharmaceuticalsDisease Models, AnimalPeptidesMembrane GlycoproteinsCell Line, Tumor

Stichwörter der Autor:innen

ATRACD38PETdaratumumabisatuximabpharmacodynamics

Substanzen

Gallium RadioisotopesADP-ribosyl Cyclase 1Gallium-68RadiopharmaceuticalsPeptidesCD38 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Chemical & Biomolecular Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
  • Department of Radiation Oncology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.

ORCID-Profile: Sridhar Nimmagadda

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIBIB NIH HHS
  • National Institutes of Health

Zitieren

APA

Sharma, A. K., Gupta, K., Mishra, A., Lofland, G., Marsh, I., Kumar, D., Ghiaur, G., Imus, P., Rowe, S. P., Hobbs, R. F., Gocke, C. B., & Nimmagadda, S. (2024). CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET. Advanced Science. https://doi.org/10.1002/advs.202308617

Vancouver

Sharma AK, Gupta K, Mishra A, Lofland G, Marsh I, Kumar D, et al. CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET. Advanced Science. 2024. doi:10.1002/advs.202308617

BibTeX
@article{Sharma2024,
  author = {Sharma, Ajay Kumar and Gupta, Kuldeep and Mishra, Akhilesh and Lofland, Gabriela and Marsh, Ian and Kumar, Dhiraj and Ghiaur, Gabriel and Imus, Philip and Rowe, Steven P and Hobbs, Robert F and Gocke, Christian B and Nimmagadda, Sridhar},
  title = {CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308617}
}
Kostenlos starten →